Testing effectiveness (Phase 2)Study completedNCT01332630What this trial is testingTPI 287 in Breast Cancer Metastatic to the BrainWho this might be right forBreast Cancer M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT03328884What this trial is testingEvaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer PatientsWho this might be right forBreast Cancer Metastatic MedSIR 55
Post-approval studies (Phase 4)Looking for participantsNCT05376878What this trial is testingAn Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain MetastasisWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain City of Hope Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT02154529What this trial is testingStudy of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast CancerWho this might be right forHER-2 Positive Breast CancerMetastatic Malignant Neoplasm to Brain Kadmon Corporation, LLC 17
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT01770353What this trial is testingMM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentWho this might be right forSolid TumorsER/PR Positive Breast CancerTriple Negative Breast Cancer+1 more Ipsen 45
Not applicableNot Yet RecruitingNCT07619534What this trial is testingCollection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain MetastasesWho this might be right forBreast CancerBreast CarcinomaCancer of the Breast+1 more National Cancer Institute (NCI) 139
Testing effectiveness (Phase 2)Active Not RecruitingNCT05892068What this trial is testingTucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the BrainWho this might be right forMetastatic Breast Cancer Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)WithdrawnNCT00397501What this trial is testingBBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWho this might be right forBrain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more OHSU Knight Cancer Institute
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Very early researchEnded earlyNCT04712721What this trial is testingStudy of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.Who this might be right forGlioblastoma MultiformeBrain NeoplasmsGastroesophageal Adenocarcinoma+1 more Novartis Pharmaceuticals 14
Not applicableStudy completedNCT01621906What this trial is testing18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the BrainWho this might be right forMetastatic Breast Cancer to the Brain Memorial Sloan Kettering Cancer Center 17
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Not applicableStudy completedNCT00755313What this trial is testingEffects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast CancerWho this might be right forBreast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more University of California, San Francisco 81
Testing effectiveness (Phase 2)Ended earlyNCT04644315What this trial is testingA Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsWho this might be right forNeoplasmsColorectal NeoplasmsMelanoma+25 more Hoffmann-La Roche 1
Not applicableStudy completedNCT01064349What this trial is testingBreast Cancer With Over-expression of erbB2-BRAINSTORMWho this might be right forCancer GlaxoSmithKline 144
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT01173497What this trial is testingA Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisWho this might be right forEstrogen Receptor Negative (ER-Negative) Breast CancerProgesterone Receptor Negative (PR-Negative) Breast CancerHuman Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer+1 more Sanofi 44
Large-scale testing (Phase 3)Study completedNCT00639366What this trial is testingRadiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast CancerWho this might be right forBreast Cancer Anglo Celtic Cooperative Oncology Group 390
Testing effectiveness (Phase 2)Looking for participantsNCT07383649What this trial is testingTrial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV InfectionWho this might be right forBrain Cancer MetastaticCMV Viremia The Methodist Hospital Research Institute 28